FLNA: SEC Form 10-Q filed by Filana Therapeutics Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for FLNA
Across the 4 sessions after earlier FLNA headlines, the stock closed higher 1 times and lower 3 times, with a median move of 3.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | FLNA | SPY |
|---|---|---|---|
| May 7, 2026 | Filana Therapeutics Reports Q1 2026 Financial Results and Business Update | -5.6% | -0.3% |
| May 5, 2026 | Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII | -1.4% | +0.8% |
| Apr 15, 2026 | Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data | +1.3% | +0.8% |
| Mar 12, 2026 | Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results | -6.7% | -1.5% |
Quantisnow market dataNASDAQ
FLNA
Filana Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for FLNA
Full FLNA profile on Quantisnow Follow FLNA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time